Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
VIRMA modulates function of photoreceptor cells through m6A modification and alternative splicing
Wenjing Liu, Xiaojing Wu, Rong Zou, Fan Zhang, Yudi Fan, Kuanxiang Sun, Liping Yang, Jiang Hu, Lin Zhang, Xianjun Zhu
Wenjing Liu, Xiaojing Wu, Rong Zou, Fan Zhang, Yudi Fan, Kuanxiang Sun, Liping Yang, Jiang Hu, Lin Zhang, Xianjun Zhu
View: Text | PDF
Research Article Neuroscience Ophthalmology

VIRMA modulates function of photoreceptor cells through m6A modification and alternative splicing

  • Text
  • PDF
Abstract

N6-methyladenosine (m6A) modification is the most prevalent posttranscriptional epigenetic modification in mammalian mRNAs, and it has been implicated in the regulation of nervous system development by modulating mRNA metabolism. VIRMA is the largest core subunit of the m6A methyltransferase complex and is essential for the assembly and stability of the m6A methyltransferase complex. In the retina, m6A methylation modification is widely distributed in various cellular layers and is essential for retinal homeostasis. Here, we demonstrate that VIRMA-mediated m6A modification is essential for retinal homeostasis. Loss of Virma in retinal rod cells resulted in abnormal reduction in m6A methylation levels, along with impaired photoreceptor function and degeneration. Mechanically, Virma depletion in photoreceptors dampened the m6A modification level of visual perception–associated genes, resulting compromised visual function and photoreceptors degeneration. Moreover, Virma interacted with splicing factor to regulate the alternative splicing events of retina function–related genes such as Polg2, which contributes to photoreceptor damage. Reintroduction of normal Virma expression colonially rescued photoreceptor degeneration. Collectively, our data elucidate the important role of Virma-mediated m6A modification in photoreceptor function and suggest that epigenetic modulation could serve as a potential target to treat these blinding diseases.

Authors

Wenjing Liu, Xiaojing Wu, Rong Zou, Fan Zhang, Yudi Fan, Kuanxiang Sun, Liping Yang, Jiang Hu, Lin Zhang, Xianjun Zhu

×

Figure 6

Virma is involved in alternative splicing of transcripts in retina.

Options: View larger image (or click on image) Download as PowerPoint

Virma is involved in alternative splicing of transcripts in retina.
(A)...
(A) Colocalization and coimmunoprecipitation analysis of VIRMA and SRSF3. Scale bar: 10 μm. (B) Seven types of alternative splicing events were identified in RKO retains. A3, alternative 3′ splice site; A5, alternative 5′ splice site; MX, mutually exclusive exon; SE, skipped exon; RI, retained intron; AF, alternative first exon; AL, alternative last exon. (C) Sashimi plot of Impdh1 gene in Ctrl and RKO retinas. (D and E) RT-PCR validation of exon 2 skipping of Impdh1 gene (Student’s t test, n = 3). (F) Wiggle plots showing intron retention of Polg2. (G and H) RT-PCR validation of intron retention of Polg2 gene in RKO retinas (Student’s t test, n = 3). (I) Western blot and RT-qPCR analysis of POLG2 expression in Ctrl and RKO mice (Student’s t test, n = 3). (J) HSP60 (a mitochondrial marker) immunofluorescence staining of shCtrl and shVIRMA 293STF cells. Scale bars: 20 μm; 5 μm (higher-magnification images). (K) ATP levels in fresh retains from 4-week-old Ctrl and RKO mice were measured using luciferase assay (Student’s t test, n = 5). (L) RT-qPCR analysis of the expression of mitochondrial function–related genes (Student’s t test, n = 4). Data are presented as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts